Taysha Gene Therapies (TSHA) Leases (2022 - 2025)
Historic Leases for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to $7.5 million.
- Taysha Gene Therapies' Leases fell 1400.09% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year decrease of 1400.09%. This contributed to the annual value of $8.4 million for FY2024, which is 1253.39% down from last year.
- Taysha Gene Therapies' Leases amounted to $7.5 million in Q3 2025, which was down 1400.09% from $7.8 million recorded in Q2 2025.
- In the past 5 years, Taysha Gene Therapies' Leases registered a high of $10.9 million during Q4 2022, and its lowest value of $7.5 million during Q3 2025.
- Over the past 4 years, Taysha Gene Therapies' median Leases value was $9.1 million (recorded in 2024), while the average stood at $9.2 million.
- Per our database at Business Quant, Taysha Gene Therapies' Leases tumbled by 1191.64% in 2024 and then tumbled by 1400.09% in 2025.
- Quarter analysis of 4 years shows Taysha Gene Therapies' Leases stood at $10.9 million in 2022, then dropped by 12.44% to $9.6 million in 2023, then decreased by 12.53% to $8.4 million in 2024, then fell by 10.95% to $7.5 million in 2025.
- Its Leases was $7.5 million in Q3 2025, compared to $7.8 million in Q2 2025 and $8.1 million in Q1 2025.